Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SSR2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MACF1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
NOP10 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TMEM167A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TM2D1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ANKRD12 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TGDS - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
BOD1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RAD23B - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SEC24B - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SRSF10 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
NUS1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RCHY1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
FAF2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
HAX1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CAND1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
FER - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ARFGAP3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
BIRC2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TPP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on